FOXA1 is a transcriptional repressor and reduces the viability and motility in liver cancer cells43, while FOXA2 inhibits EMT in HCC, breast cancer, and lung cancer37,44,45. This evidence concerns the gene FOXA1 and hepatocellular carcinoma.